英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
tamarisc查看　tamarisc　在百度字典中的解释百度英翻中〔查看〕
tamarisc查看　tamarisc　在Google字典中的解释Google英翻中〔查看〕
tamarisc查看　tamarisc　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Myelodysplastic syndromes: Updates on Genomic Landscape . . .
    Summary Several recent targeted drug approvals including luspatercept and imetelstat have greatly expanded the treatment arsenal for lower-risk MDS Standard of care therapy options for high-risk MDS, in particular TP53 -mutated, remain limited beyond HMAs and transplant and are an active area of investigation
  • Treating Myelodysplastic Syndromes | MDS Treatment
    Treating Myelodysplastic Syndromes If you’ve been diagnosed with a myelodysplastic syndrome (MDS), your treatment team will discuss your options with you It’s important to weigh the benefits of each treatment option against the possible risks and side effects
  • Myelodysplastic Syndromes Treatment (PDQ®)–Patient Version
    Myelodysplastic syndromes (MDS) treatment options include supportive care, drug therapy, and chemotherapy with allogeneic stem cell transplant Learn more about newly diagnosed or recurrent MDS and its treatment in this expert-reviewed summary
  • Updates in Treatment Options for TP53-Mutant AML and MDS
    Conclusion In summary, AML and MDS patients who have the TP53 gene mutation are encouraged to find and or meet with their specialist to discuss receiving cellular therapies through clinical trials Some of these cellular therapies include an anti-CD123 antibody or off-the-self CAR treatments, which use donor immune system cells to kill cancer
  • Whats New in Myelodysplastic Syndrome (MDS) Research?
    What's New in Myelodysplastic Syndrome (MDS) Research? Research into the causes, diagnosis, and treatment of myelodysplastic syndromes (MDS) is being done at many cancer research centers around the world
  • Myelodysplastic syndromes - Diagnosis and treatment - Mayo Clinic
    For myelodysplastic syndromes, questions to ask your doctor might include: What type of myelodysplastic syndrome do I have? Will I need more tests? What is my prognosis? What is my risk of leukemia? If I need treatment, what are my options and what do you recommend? I have other health conditions How can I best manage them together?
  • Clinical decision-making and treatment of myelodysplastic . . .
    The myelodysplastic syndromes (MDSs) constitute a profoundly heterogeneous myeloid malignancy with a common origin in the hemopoietic stem cell compartment Consequently, patient management and treatment are as heterogeneous Decision-making includes identifying risk, symptoms, and options for an individual and conducting a risk-benefit analysis
  • NCCN Guidelines for Patients: Myelodysplastic Syndromes
    Treatment options for lower-risk myelodysplastic syndromes (MDS) are based on many different factors, such as the presence of symptomatic anemia, the genetic and cytogenetic characteristics of the MDS, and your serum erythropoietin (EPO) level
  • MDS Treatment Advances: Targeted Therapies and Anemia . . .
    Learn how myelodysplastic syndrome treatment has advanced with targeted therapies and anemia management while balancing quality of life for patients
  • Clinical Study on Targeted Drug Expands Treatment Options for . . .
    The targeted drug olutasidenib is highly effective in certain patients with myelodysplastic syndrome (MDS), a condition considered incurable without transplantation, according to a new clinical study led by researchers at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine





中文字典-英文字典  2005-2009